OVIT (OncoVista Innovative Therapies) Beginning Cash Position: $0.03 Mil (As of Sep. 2015)


What is OncoVista Innovative Therapies Beginning Cash Position?

OncoVista Innovative Therapies OVIT Beginning Cash Position is $0.03 Mil as of Sep. 2015.

OncoVista Innovative Therapies's Beginning Cash Position for the quarter that ended in Sep. 2015 was $0.03 Mil.

OncoVista Innovative Therapies's quarterly Beginning Cash Position increased from Mar. 2015 ($0.01 Mil) to Jun. 2015 ($0.06 Mil) but then declined from Jun. 2015 ($0.06 Mil) to Sep. 2015 ($0.03 Mil).

OncoVista Innovative Therapies's annual Beginning Cash Position declined from Dec. 2012 ($2.13 Mil) to Dec. 2013 ($0.51 Mil) and declined from Dec. 2013 ($0.51 Mil) to Dec. 2014 ($0.05 Mil).

OncoVista Innovative Therapies Beginning Cash Position Related Terms

OncoVista Innovative Therapies Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Beginning Cash Position Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 3.52 2.13 0.51 0.05

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.08 0.01 0.06 0.03

OncoVista Innovative Therapies Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.03 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Beginning Cash Position of $0.03 Mil as of Sep. 2015. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Beginning Cash Position too high?
OncoVista Innovative Therapies' current Beginning Cash Position is $0.03 Mil.
How does OncoVista Innovative Therapies' Beginning Cash Position compare to RSPI and HSTC?
OncoVista Innovative Therapies' Beginning Cash Position of $0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Beginning Cash Position is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Beginning Cash Position of $0.03 Mil. The current Beginning Cash Position is $0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Beginning Cash Position is $0.03 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.